Corbus Pharmaceuticals Holdings, Inc.

Bank of New York Mellon Corp CRBP

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/14/2023

32,061

Value ($000)

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/14/2023	4	0.0%	32,061	12/31/2022
2022 Q3	11/14/2022	5	0.0%	34,301	9/30/2022
2022 Q2	8/15/2022	9	0.0%	34,301	6/30/2022
2022 Q1	5/11/2022	18	0.0%	34,301	3/31/2022
2021 Q4	2/11/2022	21	0.0%	34,301	12/31/2021
2021 Q3	11/18/2021	35	0.0%	34,301	9/30/2021
2021 Q2	8/11/2021	361	0.0%	197,232	6/30/2021
2021 Q1	5/13/2021	527	0.0%	267,113	3/31/2021
2020 Q4	2/9/2021	282	0.0%	226,423	12/31/2020
2020 Q3	11/12/2020	492	0.0%	272,780	9/30/2020
2020 Q2	8/12/2020	2,270	0.0%	270,618	6/30/2020
2020 Q1	5/6/2020	1,143	0.0%	217,916	3/31/2020
2019 Q4	2/14/2020	1,088	0.0%	199,193	12/31/2019